During the past decade, Humanity & Health Medical Group Limited conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Humanity & Health Medical Group Limited" #1 collaborator was "Tokyo University" with 2 trials as a collaborator and "Nihon University School of Medicine" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Humanity & Health Medical Group Limited" are "Chronic Liver Disease" (1 trials), "Hepatocellular Carcinoma" (1 trials) and "Subjects After COVID-19 Vaccination" (1 trials). Many other conditions were trialed in "Humanity & Health Medical Group Limited" in a lesser frequency.

Most popular intervention types in "Humanity & Health Medical Group Limited" are "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "AZD1222" (1 trials), "Approved COVID-19 vaccine" (1 trials), "BNT162b2" (1 trials) and "CoronaVac" (1 trials). Other intervention names were less common.

The vast majority of trials in "Humanity & Health Medical Group Limited" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Humanity & Health Medical Group Limited". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Humanity & Health Medical Group Limited, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Humanity & Health Medical Group Limited, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".